Skip to main content
TipRanks
Go Ultimate75% OFF

Lars Ekman Insider Profile

4 Followers

Lars Ekman, Director at Prothena, holds 243.00 shares in Prothena (Ticker: PRTA), holds 17.75K shares in Ultragenyx Pharmaceutical (Ticker: RARE), holds 0.00 shares in Spark Therapeutics (Ticker: ONCE).

Lars Ekman's Trading History

PRTA
Prothena
Jan 05, 2023DirectorUninformative Buy101.50K$1.98K
RARE
Ultragenyx Pharmaceutical
Jun 28, 2022DirectorUninformative Buy―$285.34K
ONCE
Spark Therapeutics
Dec 17, 2019―Uninformative Sell343.50K$0.00
AMRN
Amarin
Nov 13, 2019DirectorUninformative Buy555.84K$0.00
SPHS
Sophiris Bio
Jan 23, 2015―Informative Sell4.54K$6.24
OCRX
Ocera Therapeutics
―――$0.00
ITMN
InterMune
――――

You May Also Like

Lars Ekman insider profile FAQ

What is the percentage of profitable transactions made by Lars Ekman?
The percentage of profitable transactions made by Lars Ekman is 0%.
What is the average return per transaction made by Lars Ekman?
The average return per transaction made by Lars Ekman is -140.20%.
What stocks does Lars Ekman hold?
Lars Ekman holds: PRTA, AMRN, RARE, SPHS, ONCE, ITMN, OCRX stocks.
What was Lars Ekman’s latest transaction?
Lars Ekman’s latest transaction was an Uninformative Buy of $101.50K.
What was Lars Ekman's most profitable transaction?
Lars Ekman’s most profitable transaction was an Informative Sell of PRTA stock on November 25, 2015. The return on the trade was 0.00%.
What is Lars Ekman's role in Prothena?
Lars Ekman's role in Prothena is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.